Skip to content

Clinical trials

Thromboembolism trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Country / region: Australia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20063
20071
20081
20092
20131
20143
20152
20161
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
Bayer3
Astellas Pharma Inc2
Bristol-Myers Squibb2
Abbott Medical Devices1
Chinese University of Hong Kong1
Daiichi Sankyo1
Hamilton Health Sciences Corporation1
Janssen Research & Development, LLC1
On-X Life Technologies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism19
Stroke6
Venous Thromboembolism5
Atrial Fibrillation4
Thrombosis4
Ischemic Attack, Transient2
Pulmonary Embolism2
Venous Thrombosis2
Cerebrovascular Disorders1
Communicable Diseases1

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.